Authors
Luca Bertolaccini, Carlo La Vecchia, Francesco Sardanelli, Mãrcis Leja, Adriana Albini, Cristina Trovato, Giorgio Bogani, Francesca Magnoni, Francesco Di Bello, Franco Roviello, Viviana Galimberti, Fátima Carneiro, Rachel van der Post, Gabriella Pravettoni, Lucia Mangone, Carmen Criscitiello, Mariachiara Negrelli, Matteo Lazzeroni, Vincenzo Nicastro, Lorenzo Spaggiari, Meric A Altinoz, Jaak Ph Janssens, Giovanni Corso
Published in
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP). Jun 30, 2026. Epub Jun 30, 2026.
Abstract
Cancer screening is a cornerstone of cancer control in Europe yet marked disparities persist in access, implementation, and quality assurance among national or regional programs. Building on the EU Council's 2022 recommendations and the European Union's Beating Cancer Plan, the European Consensus Project (ECP) was established to provide harmonized, evidence-based recommendations for major cancer screening programs and to promote a shift toward risk-adapted, technology-enabled, and equitable prevention models.
A structured expert panel meeting was convened under the auspices of the European Cancer Prevention Organization, integrating systematic literature review and multidisciplinary discussion to formulate validated, evidence-based recommendations. For each primary cancer site (breast, lung, colo-rectum, cervix, prostate, and stomach), systematic literature reviews identified evidence on reductions in mortality, stage distribution, participation, cost-effectiveness, and organizational quality.
The consensus reaffirmed the evidence of mortality reduction with organized breast, lung, colorectal, and cervical screening, endorsed structured risk-adapted prostate-specific antigen testing for prostate cancer, and recommended Helicobacter pylori 'screen-and-treat' strategies for gastric cancer in high-incidence regions. Insights into future perspectives of liquid biopsy approaches are outlined.
The ECP Consensus outlines a European roadmap for precision screening, grounded in quality assurance, individual risk stratification, artificial intelligence integration, and public health literacy. These recommendations align with the EU Mission on Cancer and Europe's Beating Cancer Plan, providing a harmonized roadmap toward precision prevention and equitable implementation of screening across Europe.
PMID:
42366611
Bibliographic data and abstract were imported from PubMed on 29 Jun 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0